Amgen (AMGN) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
168.07% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-52.40% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-45.93% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-182.77% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
5.14% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
53.69% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
- |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
8.81% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
5.14% |
| Dec 31, 2025 |
112.60% |
| Sep 30, 2025 |
13.64% |
| Jun 30, 2025 |
91.96% |
| Mar 31, 2025 |
1,630.97% |
| Dec 31, 2024 |
-18.25% |
| Sep 30, 2024 |
63.58% |
| Jun 30, 2024 |
-45.90% |
| Mar 31, 2024 |
-103.98% |
| Dec 31, 2023 |
-52.54% |
| Sep 30, 2023 |
-19.27% |
| Jun 30, 2023 |
4.71% |
| Mar 31, 2023 |
92.48% |
| Dec 31, 2022 |
-14.90% |
| Sep 30, 2022 |
13.75% |
| Jun 30, 2022 |
183.84% |
| Mar 31, 2022 |
-10.33% |
| Dec 31, 2021 |
17.59% |
| Sep 30, 2021 |
-6.78% |
| Jun 30, 2021 |
-74.27% |
| Mar 31, 2021 |
-9.81% |
| Dec 31, 2020 |
-5.17% |
| Sep 30, 2020 |
2.69% |
| Jun 30, 2020 |
-17.26% |
| Mar 31, 2020 |
-8.38% |
| Dec 31, 2019 |
-11.67% |
| Sep 30, 2019 |
5.86% |
| Jun 30, 2019 |
-5.10% |
| Mar 31, 2019 |
-13.80% |
| Dec 31, 2018 |
145.22% |
| Sep 30, 2018 |
-8.02% |
| Jun 30, 2018 |
6.74% |
| Mar 31, 2018 |
11.59% |
| Dec 31, 2017 |
-320.36% |
| Sep 30, 2017 |
0.20% |
| Jun 30, 2017 |
15.03% |
| Mar 31, 2017 |
9.00% |
| Dec 31, 2016 |
7.50% |
| Sep 30, 2016 |
8.27% |
| Jun 30, 2016 |
13.13% |
| Mar 31, 2016 |
17.07% |
| Dec 31, 2015 |
39.10% |
| Sep 30, 2015 |
49.76% |
| Jun 30, 2015 |
6.85% |
| Mar 31, 2015 |
51.26% |
| Dec 31, 2014 |
26.74% |
| Sep 30, 2014 |
-9.06% |
| Jun 30, 2014 |
22.97% |
| Mar 31, 2014 |
-25.17% |
| Dec 31, 2013 |
29.57% |
| Sep 30, 2013 |
23.58% |
| Jun 30, 2013 |
-0.63% |
| Mar 31, 2013 |
21.11% |
| Dec 31, 2012 |
-15.63% |
| Sep 30, 2012 |
143.83% |
| Jun 30, 2012 |
8.21% |
| Mar 31, 2012 |
5.24% |
| Dec 31, 2011 |
-8.61% |
| Sep 30, 2011 |
-63.27% |
| Jun 30, 2011 |
-2.66% |
| Mar 31, 2011 |
-3.60% |
| Dec 31, 2010 |
9.77% |
| Sep 30, 2010 |
-10.82% |
| Jun 30, 2010 |
-5.28% |
| Mar 31, 2010 |
14.52% |
